CD20 knockout cell lines obtained using CRISPR/Cas9 have no significant defect in BCR signaling in B-lymphoid malignancies

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	KOZLOVÁ Veronika LEDEREROVÁ Aneta VAKULOVÁ Viera DOUBEK Michael MAYER Jiří POSPÍŠILOVÁ Šárka ŠMÍDA Michal
Year of publication	2017
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation
Description	CD20 knockout cell lines obtained using CRISPR/Cas9 have no significant defect in BCR signaling in B-lymphoid malignancies, CD20 knockout cell lines obtained using CRISPR/Cas9 have no significant defect in BCR signaling in B-lymphoid malignancies
Related projects:	Rezistence na léčbu monoklonálními protilátkami u B-CLL a B-lymfomů: příčiny vzniku a potenciální intervenční strategie Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IV